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Abstract
Interleukin (IL)-33 is an interleukin-1 like cytokine that enhances Th2 responses and medi-
ates mucosal immunity and allergic inflammation but the mechanism regulating endogenous
IL-33 production are still under investigation. In macrophages, lipopolysaccharide (LPS)
administration resulted in marked induction of IL-33 mRNA that was blunted in macro-
phages from glutaredoxin-1 (Glrx) knockout mice and in RAW264.7 macrophages with Glrx
knockdown by siRNA. Glutaredoxin-1 is a small cytosolic thioltransferase that controls a
reversible protein thiol modification, S-glutationylation (protein-GSH adducts), thereby regu-
lating redox signaling. In this study, we examined the mechanism of Glrx regulation of
endogenous IL-33 induction in macrophages. Glrx knockdown resulted in impaired de-glu-
tathionylation of TRAF6, which is required for TRAF6 activation, and inhibited downstream
IKKβ and NF-κB activation. Inhibitors of NF-κB suppressed IL-33 induction and chromatin
IP sequencing data analysis confirmed that IL-33 is an NF-κB-responsive gene. Since
TRAF6-NF-κB activation is also essential for IL-33 signaling through its receptor, ST2L, we
next tested the involvement of Glrx in exogenous IL-33 responses in RAW264.7 cells.
Recombinant IL-33 (rIL-33) administration induced IL-33 mRNA expression in RAW264.7
macrophages, and this was inhibited by Glrx knockdown. Interestingly, rIL-33-induced IL-33
protein was identified as the 20 kDa cleaved form whereas LPS-induced IL-33 protein was
identified as full-length IL-33, which may be less active than the cleaved form. In a clinically-
relevant mouse model of asthma, intra-tracheal cockroach antigen treatment induced Glrx
protein in wild type mouse lungs but Glrx induction was attenuated in IL-33 knockout mouse
lungs, suggesting that IL-33 may regulate Glrx induction in vivo in response to allergen chal-
lenge. In summary, our data reveal a novel mechanism by which Glrx controls both LPS-
and IL-33-mediated NF-κB activation leading to IL-33 production, and paracrine IL-33 can
induce Glrx to further regulate inflammatory reactions.
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Introduction
IL-33 is a member of the IL-1 family that was identified as the ligand of the orphan receptor,
ST2L (formal name, IL-1 receptor-like 1, IL1RL1), and transduces signals through transmem-
brane ST2L receptor via TNF receptor-associated factor 6 (TRAF6) [1]. IL-33 is known to
enhance Th2 responses and mediate allergic reactions [1,2]. Endogenous IL-33 contributes to
innate-type mucosal immunity and allergic airway inflammation [3–5].
IL-33 is constitutively stored in the nucleus of certain barrier cell types including epithelial
cells and endothelial cells [6–8], and in the later, may function as a transcriptional regulator
[6,9] although a recent report refutes this [10]. Alternaria alternata exposure in the airways of
mice and in vitro induces rapid release of IL-33 by epithelial cells into the extracellular milieu.
In this setting, ATP mediated activation of purinergic receptors and sustained increases in cal-
cium are responsible for IL-33 release both in vitro and in vivo [11].
IL-33 is not constitutively expressed in monocytes and macrophages, rather, it is induced
by the bacterial endotoxin, lipopolysaccharide (LPS) [1,12–14] and is released from injured or
dying cells [11,13,15]. In macrophages, IL-33 plays a role in polarization to alternatively-acti-
vated M2 macrophages that may be involved in wound healing [16–18]. A recent study showed
that Ly6C-positive F4/80-positive monocytes population was a major source of IL-33 and con-
tributed to allergic inflammation in the lungs following house dust mite stimulation [19], indi-
cating that inducible IL-33 in monocytes may be an important player in allergic lungs. IL-
33-deficient mice show diminished systemic inflammatory responses to LPS [3] while para-
crine IL-33 enhances LPS-induced inflammatory cytokines in macrophages [20], suggesting
interaction and/or augmentation in signaling between IL-33 and the LPS-toll like receptor
(TLR) 4 pathway.
LPS also induces glutaredoxin-1 (Glrx), a small cytosolic thioltransferase that specifically
reverses glutathione (GSH) adducts (S-glutathionylation) from protein thiols [21]. Glrx-medi-
ated GSH-protein adduct reversal (de-glutationylation) is emerging as an important mecha-
nism for cellular redox signaling including regulation of inflammatory pathways in a number
of disease models and settings [22,23]. Glrx deletion enhances GSH adduct formation on key
signaling proteins including those of the NF-κB pathway resulting in NF-κB inactivation by
inhibiting IKKβ and p50 DNA binding [24,25] and decreased pro-inflammatory cytokine
release in alveolar macrophages [21]. On the other hand, increased Glrx levels activate NF-κB
through reversal of GSH adducts [26,27]. In the present study we examined the mechanism of
Glrx regulation of IL-33 RNA and protein induction in macrophages. We report the novel
finding that Glrx regulates both LPS-induced and IL-33-induced IL-33 production in macro-
phages via regulation of TRAF6-NF-κB activation; however, independent of Glrx regulation,
IL-33-induced IL-33 protein was a processed short form that is likely to be more bioactive
compared to LPS-induced IL-33. Finally, we provide in vivo evidence that our findings of
reciprocal regulation between IL-33 and Glrx may be involved in a mouse model of asthma.
Materials and methods
Reagents
Lipopolysaccharide (L6529) was obtained from Sigma-Aldrich. Recombinant mouse IL-33
was from R&D Systems. Antibodies were obtained from the following sources; anti-mouse IL-
33 (goat polyclonal, AF3626) was from R&D Systems, anti-TRAF6 (rabbit polyclonal) and
anti-IκBα (rabbit polyclonal) were from Santa Cruz Biotechnology, anti-mouse Glrx (rabbit
polyclonal, BL3725) was from IMCO/Cayman or custom-made by Bethyl Laboratories, Inc.,
anti-thioredoxin-1 was a generous gift from Dr. J. Sadoshima (Rutgers New Jersey Medical
Redox regulation of IL-33 in macrophages
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School). Rabbit monoclonal antibody to Phospho-IKKα/β (Ser176/180) was from Cell Signal-
ing. MG132 was obtained from Cayman, and JSH-23 was from EMD Chemicals, Inc. High
Capacity RNA-to-cDNA kit, TaqMan Gene Expression Master Mix, TaqMan assays and Ste-
pOne Real-Time PCR Systems were from Applied Biosystems Thermo Fisher Scientific. Ger-
man cockroach antigen was obtained from Stallergenes Greer.
Mouse peritoneal macrophages
Glrx knockout (KO) mice were generated by Dr. Y-S. Ho (Wayne State University, MI) [28].
Homozygous Glrx KO and genetically-matched wild type (WT) control mice were transferred
and bred in the Laboratory Animal Science Center (LASC) on the Boston University Medical
Campus as approved by Institutional Animal Care and Use Committee at Boston University.
Mice were euthanized by carbon dioxide inhalation according to a protocol approved by Bos-
ton University Animal Care and Use Committee. Peritoneal macrophages were collected from
WT and KO mice (8–10 months old) by injection of cold PBS containing glucose into the peri-
toneal cavity immediately after euthanasia and collection of peritoneal fluid. Cells from 4–5
mice were pooled and centrifuged at 1000 rpm, re-suspended in DMEM containing 10% FBS,
and plated into 24 wells. After one hour, cells were washed with warm PBS to remove non-
adherent cells and adherent cells were cultured in DMEM +10% FBS with penicillin-strepto-
mycin [29]. The following day the medium was changed, and cells were treated with LPS (100
ng/ml) for 6 hours followed by RNA extraction. Before LPS stimulation an aliquot of cells was
fixed with 4% paraformaldehyde and stained with anti-mouse F4/80 antibody (BioLegend).
F4/80 positive cells assessed by Image J of total cell number which was counted by Hoechst
staining,
RAW 264.7 macrophage culture and Glrx knockdown by siRNA
Mouse macrophage cell line, RAW 264.7, was obtained from ATCC (TIB-71) and cultured in
DMEM with 10%FBS and 4.5 mg/L glucose as instructed. To knock down expression of Glrx,
approximately 5 X 105 cells were plated in 6-well plates. Adherent cells were transfected with
siRNA for mouse Glrx-1 (Invitrogen): sense: GCAGAAAGACCCAAGAAAU, antisense: AUUUC
UUGGGUCUUUCUGC (Glrx siRNA) or scrambled RNA (Con siRNA) at a final concentration
of 125 nM using Lipofectamine 2000 (Invitrogen) in the medium containing 10% FBS without
antibiotics. After 2 days in culture the medium was replaced with DMEM containing 1% FBS,
followed by treatment with LPS (100 ng/ml) or IL-33 (10–25 ng/ml). For some experiments,
confluent cells were treated with LPS in DMEM containing 1% FBS after incubation with
inhibitors for 30 minutes.
Biotinylated GSH Ester (BioGEE) and detection of GSH-protein adducts
To detect GSH-protein adduct formation, the method originally described [30] was applied
with slight modifications. Briefly, BioGEE was made by mixing EZ-Link Sulfo-NHS-Biotin
(Pierce) with GSH ethyl ester in 50 mM NaHCO3 at pH 8.5 for 2 h followed by addition of 250
mM NH4HCO3 (pH 8.5) to quench remaining biotinylation reagent. Purified BioGEE was a
generous gift from Dr. M. Bachschmid (Boston University). Confluent RAW264.7 cells, after
Glrx siRNA or Con siRNA treatment, were incubated with 100 μM BioGEE in DMEM with
1% FBS for 2 hours with or without LPS. Cells were washed in HBSS with 100 mM N-ethylma-
leimide for 5 minutes, followed by collecting in lysis buffer (Cell Signaling Technology #9803)
containing 100 mM N-ethylmaleimide, 1% SDS, 1 mM phenylmethylsulfonyl fluoride. Cell
lysates were sonicated on ice, incubated at 50˚C for 20 minutes with shaking to block free thi-
ols and centrifuged at 1000 rpm for 5 min. The supernatant was passed through a PD-10
Redox regulation of IL-33 in macrophages
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Sephadex-G25 column to remove excess BioGEE, and an equal amount of eluted protein was
mixed with streptavidin-Sepharose beads overnight at 4˚C. Beads were washed with lysis
buffer 4 times and the final precipitate was incubated in Laemmli buffer with 5% β-mercap-
toethanol and 5M urea, followed by separation by SDS-PAGE. TRAF6 was detected by immu-
noblotting with polyclonal anti-TRAF6 antibody.
RT-qPCR
Total RNA was isolated from macrophages using Trizol (Invitrogen) followed by DNase diges-
tion. RNA was reversed transcribed to cDNA using High Capacity RNA to cDNA kit
(4387406, Thermo Fischer Scientific). Relative quantitative PCR (qPCR) was performed using
gene-specific TaqMan primers (Invitrogen). TaqMan assays used were: Glrx Mm00728386_s1,
Il10 Mm01288386_m1, Il33 Mm00505403_m1, ST2L (Il1rl1) Mm01233982_m1. β-actin
(mouse 4352933) was used to normalize the expression. Expression levels were analyzed by
comparative Ct (ΔΔCT) with StepOneTM real-time PCR software (Applied Biosystems).
Western Blotting and ELISA
Protein concentration was assessed in cell lysates by Bio-Rad DC assay (500–0112, Bio-Rad
Laboratories). Equal amounts of protein in each sample in Laemmli buffer were run on 4–12%
SDS-PAGE gels. Proteins were transferred onto supported PVDF membranes and blocked
with 3% milk. Primary antibodies were incubated overnight at 4˚C in 3% albumin in PBST.
Horseradish peroxidase (HRP)-conjugated secondary antibodies were used. Blots were imaged
for chemiluminescence on films or by Kwik Quant Imager. Mouse IL-33 ELISA was purchased
from eBioscience.
Cockroach antigen-stimulation in IL-33 knockout mouse lungs
IL-33 KO mice and wild type control mice were generated as described elsewhere and geno-
type was confirmed by PCR (Smith J et al, submitted). Briefly, cockroach antigen (CRA, Greer
Laboratories) was administrated intratracheally to produce allergic lung inflammation [31].
Lungs were harvested 4 hours after the last intratracheal administration. Expression of Glrx
was performed using Western blotting.
Statistics
Data are expressed as mean ± SE. Statistical comparisons were performed by Student’s t-test or
two-way ANOVA followed by Bonferroni post-test. Statistical significance was accepted when
P was less than 0.05.
Results
LPS-induced IL-33 gene expression was markedly inhibited in peritoneal
macrophages from Glrx KO mice
IL-33 gene expression following in vitro challenge with lipopolysaccharide (LPS) was exam-
ined in mouse peritoneal macrophages from Glrx KO and WT mice by relative quantitative
RT-PCR and standardized by β-actin expression. Immunostaining of isolated peritoneal cells
in culture showed 82% cells were positive for the macrophage marker, F4/80 (S1 Fig). After
exposure to LPS (100 ng/ml) for 6 hours, IL-33 was highly induced by LPS in WT cells and
this induction was strikingly inhibited in Glrx KO cells. (Fig 1A) WT basal expression equal to
1; WT + LPS was 2454 ± 168 and KO + LPS was 171 ± 26, n = 3, p<0.01). Expression of
IL1RL1 (ST2L), which encodes the full-length transmembrane IL-33 signaling receptor, was
Redox regulation of IL-33 in macrophages
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not altered by LPS stimulation in WT cells but was significantly higher in Glrx KO cells (RQ:
WT+LPS 1.79 ± 0.07, KO+LPS 3.92 ± 0.35, n = 3, p<0.05) (Fig 1B). Glrx was also strongly
induced by LPS in WT cells and this induction was, as expected, absent in Glrx KO cells (Fig
1C). IL-10, which is known as an anti-inflammatory gene was also induced by LPS in WT cells
and this induction was also inhibited in Glrx KO cells (Fig 1D). These data were further con-
firmed using RAW264.7 macrophages to examine Glrx-mediated regulation of signaling in
macrophages.
Glrx knockdown attenuated LPS-induced IL-33 in RAW264.7 mouse
macrophages
To examine signaling pathways in Glrx-regulated IL-33 induction, Glrx was knocked down by
siRNA in RAW264.7 mouse macrophages. Comparable to our observations in peritoneal mac-
rophages from Glrx KO and WT mice, LPS-induced IL-33 mRNA expression was significantly
inhibited by Glrx knockdown (Fig 2A). In addition, ST2L mRNA expression was higher fol-
lowing Glrx knockdown compared to siCont in the absence of LPS, and its expression was fur-
ther stimulated by LPS (Fig 2B); a finding that was different from the response in peritoneal
macrophages. As was the case in peritoneal macrophages, IL-10 mRNA levels in response to
LPS were also diminished following knockdown of Glrx (Fig 2D).
Fig 1. LPS-induced IL-33 gene expression was inhibited in peritoneal macrophages from Glrx KO mice. Isolated
peritoneal macrophages from WT or Glrx KO mice were seeded overnight and stimulated with LPS (100 ng/ml) for 6
hours, followed by RNA isolation and RT-qPCR. Relative quantity (RQ) was standardized by β-actin expression. LPS-
induced expression of (A) IL-33, (B) ST2L, (C) Glrx, and (D) IL-10, each were inhibited in Glrx KO macrophages
compared to WT macrophages. Expression of ST2L, the receptor for IL-33, was higher in Glrx KO macrophages with
or without LPS. Control (C) is no LPS. n = 3. �� p<0.01, ��� p<0.001 show the difference between C vs LPS in the same
genotype of mice (One-way ANOVA).
https://doi.org/10.1371/journal.pone.0210827.g001
Redox regulation of IL-33 in macrophages
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IL-33 protein levels were analyzed by Western blotting and ELISA using RAW264.7 cell
lysates. LPS (100 ng/ml) treatment resulted in increased IL-33 as well as Glrx protein levels in
a time-dependent manner up to 18 hours. Glrx knockdown strongly attenuated LPS-induced
IL-33 protein expression detected by Western blotting (Fig 3A) as well as by ELISA (Fig 3B).
Expression of thioredoxin, a thiol-reducing enzyme, was not changed by either LPS treatment
or Glrx knockdown (Fig 3A).
NF-κB is involved in IL-33 induction
To determine whether IL-33 is an NF-κB responsive gene in macrophages in response to LPS,
we performed studies in vitro to analyze IL-33 induction using NF-κB inhibitors, MG132 and
Fig 2. LPS-induced IL-33 expression in RAW267.4 macrophages with Glrx knockdown. RAW267.4 cells were
treated with control siRNA (siCont) or Glrx siRNA (siGlrx). The media was replaced with 1% FBS media followed by
stimulation with LPS (100 ng/ml) for 6 hours. Relative quantity (RQ) was assessed with β-actin and normalized by the
basal level of siCont (n = 3, �p<0.05, �� p<0.01, ��� p<0.001 show the difference between C vs LPS). The induction of
(A) IL-33 was significantly inhibited, (B) ST2L expression was up-regulated by Glrx knockdown. (C) Glrx, (D) IL-10.
Similar results were obtained in at least 3 independent experiments.
https://doi.org/10.1371/journal.pone.0210827.g002
Fig 3. IL-33 protein levels were inhibited by Glrx knockdown. (A) IL-33 were assessed by Western blot in
RAW267.4 cell lysates after stimulation with LPS (100 ng/ml) for 6–18 hours. β-actin expression is shown as a loading
control. (B) IL-33 protein was also measured by ELISA after 18 hours LPS stimulation in RAW267.4 cells (n = 3, �
p<0.05, ��� p<0.001 from Control of each siRNA).
https://doi.org/10.1371/journal.pone.0210827.g003
Redox regulation of IL-33 in macrophages
PLOS ONE | https://doi.org/10.1371/journal.pone.0210827 January 25, 2019 6 / 15
JSH23. These studies showed inhibition of LPS-induced IL-33 induction at mRNA (Fig 4A)
and protein levels (Fig 4B). Also, ChIP seq data from macrophages treated with LPS followed
by pulldown with p65 antibody was extracted from Barish GD et al [32] and subjected to anal-
ysis using the UCSC Genome Browser. A major peak on chromosome 19 and annotated as IL-
33 was identified resulting from treatment of macrophages with LPS that was not present in
macrophages without LPS treatment (Fig 4C).
NF-κB pathway is inhibited by Glrx knockdown
Glrx inhibition may inactivate NF-κB via GSH adducts on IKKβ. We tested the NF-κB signal-
ing pathways and found that LPS-induced phosphorylation of IKKβ was significantly attenu-
ated following Glrx knockdown in RAW264.7 cells (Fig 5A). IKKβ phosphorylates IκBα and
results in its degradation and nuclear translocation of NF-κB subunits. As expected, LPS-
induced degradation of IκBα was significantly inhibited by Glrx knockdown (Fig 5B). We
next examined TRAF6, further upstream of IKKβ.
GSH adduct formation of TRAF6 was prolonged in RAW264.7 cells with
Glrx knockdown
It has been shown that TNF receptor-associated factor 6 (TRAF6) is modified with GSH
adducts and its ubiquitin ligase activation requires Glrx [33]. TRAF6 is an upstream signaling
molecule of IKKβ. To detect GSH adducts formation on TRAF6, RAW264.7 cells were incu-
bated with biotinylated GSH ester followed by pull down with Streptavidin beads. TRAF6 was
detected as a GSH-labeled protein, and the GSH-TRAF6 adducts tended to be increased in
Fig 4. IL-33 gene is NF-κB responsive and has p65-binding site. Confluent RAW267.4 cells in 1%FBS media were
treated with the NF-κB inhibitors, MG132 (10 μM) or JSH23 (5 μM, IC50 = 7.1 μM) for 30 minutes, followed by LPS
(100 ng/ml) stimulation for 6 hours. (A) IL-33 mRNA levels. (B) Left: Representative Western blotting showing IL-33
protein induction was inhibited following treatment with NF-κB inhibitors. Glrx induction was also attenuated by the
inhibitors. Right: Densitometry analysis of Glrx expression. (n = 3, �p<0.05, ��p<0.01 compared to control) (C) ChIP
seq data from macrophages treated with LPS followed by pulldown with p65 antibody was extracted from the data
obtained by Barish GD et al. Genes and Development 2010 [32]. The IL33 gene nucleotide sequence residing on
chromosome 19 was isolated and subjected to analysis using the UCSC Genome Browser. Highlighted in red (top) is
the major peak in ChIP seq data resulting from treatment of macrophages with LPS that is not present in macrophages
with no LPS treatment. Enlarged section of this region (bottom) shows approximately 80 nucleotide region that is the
putative NF-κB (p65) responsive element.
https://doi.org/10.1371/journal.pone.0210827.g004
Redox regulation of IL-33 in macrophages
PLOS ONE | https://doi.org/10.1371/journal.pone.0210827 January 25, 2019 7 / 15
Glrx knockdown cells under basal conditions. LPS treatment removed GSH adducts following
60 minutes in control cells, but, at this time, GSH adducts remained in Glrx knockdown cells
(Fig 5C). This data indicates that endogenous Glrx regulates GSH adducts on TRAF6 and its
activation in response to TLR4 activation.
Exogenous IL-33 induces Glrx and IL-33 in macrophages
The relation between exogenous IL-33 and endogenous IL-33 induction is not known. Since
TRAF6 is essential for IL-33 signaling [34] and expression of its receptor, ST2L, is upregulated
by Glrx knockdown, the effects of IL-33 on the induced expression of IL-33, ST2L, and Glrx
were examined in RAW264.7 cells. Recombinant IL-33 (rIL-33) (10–25 ng/ml) induced
mRNA of Glrx as well as IL-33, and Glrx inhibition significantly attenuated this induction (Fig
6A). In contrast, ST2L was upregulated by Glrx knockdown in the presence of IL-33 similar to
this observation following LPS stimulation (Figs 1 and 2). Interestingly, rIL-33-induced IL-33
protein was found to be of smaller size (20 kDa), which may be a cleaved, potent form [35,36],
not the full-length form of IL-33 (~30 kDa) that is induced in response to LPS (Fig 6B). These
data suggest that LPS and IL-33 share the common signaling pathway via Glrx-regulated
TRAF6-NF-κB activation leading to IL-33 production in macrophages.
Endogenous IL-33 in vivo is required for Glrx protein induction in
cockroach antigen (CRA)–stimulated mouse lungs
In CRA-stimulated mouse lungs from WT and IL-33 KO mice, protein levels of Glrx were
increased compared to saline-treatment in WT mice in response to CRA, but Glrx induction
was attenuated in lungs from IL-33 KO mice (Fig 7). This indicates that endogenous IL-33 in
vivo promotes Glrx induction following allergen stimulation.
Fig 5. LPS-induced NF-κB is inactivated by Glrx knockdown via TRAF6–IKKβ inactivation. (A) LPS (100 μg/ml)-
induced phosphorylation of IKKβ (15 min, 30 min) was attenuated in RAW267.4 cells treated with siGlrx. The
representative Western blot and densitometry analysis from 4 independent experiments are shown. �p<0.05 compared
to control. (B) Western blotting show that LPS (100 μg/ml)-induced IκBα degradation was inhibited by knockdown of
Glrx. Densitometric analysis of 3 experiments shows significant retention of IκBα which may attenuate NF-κB nuclear
translocation. (C) RAW267.4 cells were treated with siCont or siGlrx for 2 days prior to the experiment. Biotin-GSH
ester was loaded for 2 hours in RAW267.4 cells with or without LPS for the indicated times. Biotin-labeled proteins
were pulled down, separated by SDS-PAGE and blotted with TRAF6 antibody. Details are described in Methods.
Representative data showing GSH-TRAF6 adducts are shown in the upper panel. TRAF6 and Glrx expression in whole
cell lysate are shown in the lower panel. Densitometry of GSH-labelled TRAF6 was assessed as basal conditions (no
LPS) of control cells set at 1. The graph shows the average of 3 separate experiments (n = 3, � P<0.05). Retention of
GSH adducts on TRAF6 indicates impaired activation of TRAF6 [33].
https://doi.org/10.1371/journal.pone.0210827.g005
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Fig 6. Exogenous IL-33 induces Glrx and IL-33 in macrophages. RAW267.4 cells were stimulated by rIL-33 (10, 25
ng/ml) for 6 hrs after treatment with siCont or siGlrx. (A) Gene expression of IL-33, Glrx, and ST2L was assessed by
RT-qPCR. (B) rIL-33-induced IL-33 protein was truncated form compared to LPS-induced IL-33, and induction was
attenuated by siGlrx. ���p<0.001 shows difference from control (no IL-33) in each siRNA group.
https://doi.org/10.1371/journal.pone.0210827.g006
Fig 7. Glrx expression in cockroach antigen (CRA)-induced allergic lungs. WT and IL-33 KO mice were treated
with CRA as described in the methods. Glrx protein expression in the lungs was examined by Western blotting.
Relative expression of Glrx to β-tubulin by densitometry was compared between Saline and CRA treated lungs.
Expression of Glrx protein in response to CRA was diminished in IL-33 KO mice compared to WT mice. (n = 5–7
mice/group, ��p<0.01, ���p<0.001).
https://doi.org/10.1371/journal.pone.0210827.g007
Redox regulation of IL-33 in macrophages
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Discussion
Protein-glutathione (GSH) adducts, or S-glutathionylation, are oxidative thiol modifications
that may alter cellular protein function including signaling and transcriptional activity. Glutar-
edoxin-1 (Glrx) has been recognized as an important regulator of redox signaling by control-
ling levels of protein-GSH adducts in various pathophysiological conditions. The bacterial
endotoxin, LPS, significantly induced Glrx expression in macrophages, which activated NF-κB
likely through reversing GSH adducts (de-glutationylation) [26,27]. Our data further indicate
that in macrophages LPS-induced Glrx plays an important role in TRAF6 activation, the
upstream signaling molecule of IKKβ leading to NF-κB activation. This study demonstrates
the novel role of cellular Glrx on the regulation of IL-33 production via TRAF6 in LPS-stimu-
lated macrophages. Furthermore, we demonstrate that administration of rIL-33 in macro-
phages results in increased expression of both IL-33 and Glrx, and this is pathway is also
dependent on Glrx.
TRAF6 is an adaptor molecule essential for MyD88-dependent TLR4 signaling [37] as well
as IL-33 signaling [20,34]. TRAF6 is an E3 ubiquitin ligase that causes Lys-63-linked auto-
poly-ubiquitination leading to activation of both IKK and mitogen-activated protein kinases
(MAPKs) pathways. Chantzoura et al. show that TRAF6 is modified with the addition of GSH
adducts at the amino terminal RING domain, the site of E3 ubiquitin ligase activity [33]. Glrx-
dependent removal of GSH on TRAF6 is crucial for auto-polyubiquitination and subsequent
activation of IKKβ in response to IL-1 in HEK293 or HeLa cells [33]. Consistent with their
report, we demonstrated that TRAF6 was S-glutathionylated under basal conditions in macro-
phages and this was reversed by LPS stimulation. This is similar to β-actin, which undergoes
deglutathionylation in response to growth factor stimulation leading to functional changes
including actin polymerization and reorganization [38]. Our data also confirm that Glrx was
responsible for deglutathionylation because GSH adducts on TRAF6 remained after LPS stim-
ulation under Glrx knockdown conditions. Glrx itself is an NF-κB-responsive gene [26] and
its expression increases following LPS stimulation, but the mechanism by which Glrx is acti-
vated within one hour remains unclear. Although LPS-induced IL-33 induction is almost
completely blocked by the NF-κB inhibitor, JSH23, in our experiments, Glrx induction was
only partially inhibited. Other transcription factors including AP-1 [39] may regulate LPS-
induced Glrx transcription.
Furthermore, IL-33 downstream signaling requires TRAF6 [20,34,40]. Therefore, when
TRAF6 is inactivated by Glrx knockdown, IL-33 signaling as well as its production are limited.
We found that exogenous rIL-33 induced Glrx and also IL-33 mRNA was dependent on Glrx
expression in macrophages. Interestingly, rIL-33 induced IL-33 protein as a short, cleaved
form. Unlike IL-1β, full-length IL-33 is active without processing by caspases [41,42]. It has
been recently shown, however, that elastase or proteases cleave IL-33 to smaller forms that pos-
sess much higher bioactivity compared with the full-length IL-33 [35,36]. In addition, the
short form has cysteine residues that can form disulfides by oxidation and result in a shift on
the gel [43]. We confirmed the shift in a non-reduced gel (S2 Fig) but Glrx knockdown did
not change the shift or size of IL-33. Therefore, Glrx likely controls IL-33 induction at tran-
scriptional levels. The reason why rIL-33 induced a cleaved form of IL-33 is unknown and
requires further investigation.
The expression of the IL-33 receptor, ST2L (IL1RL1), was elevated in Glrx knockdown
macrophages. LPS did not show additional increase in Glrx KO mouse macrophages (Fig 1),
but its expression was enhanced further in RAW cells with siGlrx (Fig 2). The difference in
LPS response may arise from either cell type and/or complete Glrx deletion versus partial Glrx
inhibition. In RAW cells, either LPS or IL-33 upregulated ST2L expression under Glrx
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knockdown conditions (Fig 2 and Fig 6). We speculate that TRAF6 signaling negatively regu-
lates ST2L expression, and TRAF6 inhibition by Glrx knockdown may activate ST2L induc-
tion. It is reported that Th2 stimulation enhanced ST2L expression while IFN-gamma
decreased it in T cells [44]. The transcriptional regulation of ST2L has to be further explored.
Notably, IL-33 signaling is impaired in Glrx knockdown cells, therefore upregulated ST2L
could be a compensatory response to the diminished IL-33 axis.
Our findings are highly relevant to conditions that result in oxidative stress such as cigarette
smoke that decreases Glrx mRNA and protein expression [45], which may lead to lower pro-
duction of IL-33, and in addition may oxidize IL-33 to be inactivated [43]. IL-33 is beneficial
in the setting of wound healing [16] but exacerbates allergic inflammation in some models of
asthma [46]. Therefore, regulation of IL-33 by Glrx can be beneficial or deleterious depend on
the pathological conditions.
As we found the link between Glrx and IL-33 signaling in macrophages, we extended the
findings to examine expression of Glrx and IL-33 in a relevant mouse model of asthma. Cock-
roach antigen (CRA)-stimulated lungs expressed high levels Glrx protein compared to saline
treated lungs. Glrx expression was attenuated in IL-33 KO mouse lungs. Although lungs con-
tain various types of cells other than macrophages, this data suggests IL-33 may promote Glrx
expression and inflammatory reaction in allergic lungs. Also, we tested CRA-induced Glrx
mRNA in macrophages from IL-33 KO mice. We could detect CRA-induced Glrx at 6 hours,
but it was not significantly inhibited in IL-33 KO cells (S3 Fig). This suggests that CRA-
induced Glrx mRNA induction may not require IL-33 following short exposure. However,
chronic stimulation in vivo may attenuate Glrx protein levels in the lung containing various
cell types in the absence of IL-33. In addition, others have shown that Glrx expression is
increased in ovalbumin-induced or house dust mite-induced allergic airway model in mice
[47,48]. Increased Glrx further activates NF-κB and may promote IL-33 production as a recent
report shows oxidative stress enhances IL-33 in human airway epithelial cells [49].
Furthermore, we tested CRA-induced IL-33 in RAW cells, and found CRA induced IL-33
protein (full length) at 6 hours but the expression was not inhibited with siGlrx (S4 Fig). We
speculate that CRA signaling is different from LPS pathway and induces IL-33 in macrophages
under inhibition of Glrx. In a similar allergic in vivo model, Glrx ablation attenuated Th2 cyto-
kines (IL-13, IL-5) in the house dust mite-stimulated lungs although IL-33 levels were not
reported [48]. CRA-induced IL-33 may be modulated in other types of cells (epithelial, endo-
thelial) in the lungs of Glrx KO mice. Further investigation is required to clarify these issues.
In conclusion, LPS-induced Glrx activates NF-κB pathways by regulating GSH adducts on
TRAF6, thereby contributing to IL-33 production in macrophages. Exogenous IL-33 also stim-
ulates Glrx induction and active IL-33 production.
Supporting information
S1 Fig. F4/80 staining on mouse peritoneal macrophages. Adhered peritoneal cells were
fixed and stained with anti-mouse F4/80 antibody (red) and Hoechst (blue).
(PDF)
S2 Fig. IL-33-induced IL-33 protein is shifted in non-reduced condition. LPS (100ng/ml) or
IL-33 (50 ng/ml) was added in RAW cells for 6 hours, and cellular proteins were analyzed in
reduced and non-reduced gel.
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S3 Fig. CRA-induced Glrx mRNA in WT and IL-33 KO mouse macrophages. CRA (Cock-
roach antigen 100 μg/ml) or PBS was added in isolated mouse macrophages from WT and IL-
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33 KO mice. After 6 hours RNA was isolated from cells by Trizol and Glrx expression was
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S4 Fig. CRA-induced IL-33 in RAW cells. Different doses of CRA (0–80 μg/ml) was tested to
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